Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Kazuya Kuraoka"'
Autor:
Atsushi Kagimoto, Akihisa Saito, Kazuya Kuraoka, Kikuo Nakano, Yoshinori Yamashita, Kiyomi Taniyama, Akira Ishikawa, Tadashi Senoo, Tetsu Hirakawa, Takeshi Mimura, Kazuhide Fukuhara, Junichi Zaitsu, Mineyo Mito
Publikováno v:
Anticancer Research. 41:3673-3682
AIM This study aimed to investigate useful prognostic factors of immunotherapy in patients with lung cancer. PATIENTS AND METHODS We retrospectively observed 73 patients who underwent immunotherapy (nivolumab, pembrolizumab, and atezolizumab) for lun
Autor:
Takuro Hamada, Toshio Kuwai, Yuzuru Tamaru, Naoto Hadano, Riho Moriuchi, Hirona Konishi, Naoyuki Toyota, Junichi Zaitsu, Kaoru Wada, Ryusaku Kusunoki, Kazuya Kuraoka, Atsushi Yamaguchi, Kanae Tao, Kohei Ishiyama, Hiroshi Kohno, Hirotaka Kouno, Takeshi Sudo
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background Intraductal tubulopapillary neoplasm (ITPN) of the pancreas is a new disease concept defined by the World Health Organization in 2010. ITPN progresses with tubulopapillary growth in the pancreatic duct and is known to have a fair prognosis
Autor:
Takashi Kurashige, Hiroyuki Morino, Tomomi Murao, Yuishin Izumi, Tomohito Sugiura, Kazuya Kuraoka, Hideshi Kawakami, Tsuyoshi Torii, Hirofumi Maruyama
Publikováno v:
JAMA neurology. 79(7)
Degeneration of neuromuscular junctions and axons is considered an important aspect of the pathomechanism of amyotrophic lateral sclerosis (ALS). However, a mechanism including the role of transactive response DNA-binding protein 43 (TDP-43) in axons
Autor:
Hidehiko Takigawa, Naoki Yorita, Kazuya Kuraoka, Ryo Yuge, Atsushi Ono, Yasuhiko Kitadai, Shinji Tanaka, Kazuaki Chayama, Toshio Kuwai
Publikováno v:
Cancer Letters. 498:111-120
Despite recent advances in cancer immunotherapy, the efficacy of colorectal cancer (CRC) immunotherapy regimens is limited. This study evaluated the combined effect of an anti-PD-1 antibody and a platelet-derived growth factor receptor inhibitor (ima
Autor:
Tatsuya Miyamoto, Kazuya Kuraoka, Taketoshi Asanuma, Takeshi Mimura, Chika Nakashima, Atsushi Kagimoto, Yoshinori Yamashita, Yuko Mizutani
Publikováno v:
The Annals of Thoracic Surgery. 109:1692-1699
Background The choice between electrocautery or automatic suturing instruments for dissection of the lung parenchyma along the intersegmental plane during lung segmentectomy remains controversial. We hypothesized that a novel microwave surgical instr
Autor:
Jun Teishima, Daiki Taniyama, Masanobu Shigeta, Takeshi Hagura, Xiangrui Han, Takashi Babasaki, Tetsutaro Hayashi, Kazuya Kuraoka, Keisuke Goto, Shogo Inoue, Kazuhiro Sentani, Akio Matsubara, Wataru Yasui, Yohei Sekino
Publikováno v:
Anticancer Research. 40:1943-1951
Background/aim Targeted receptor tyrosine kinase inhibitor (TKI) is a standard treatment in advanced renal cell carcinoma (RCC). However, the role of PTEN in TKI resistance remains poorly understood. We aimed to determine the functional role of PTEN
Autor:
Tomohito Sugiura, Naoko Mine, Tsuyoshi Torii, Yukiko Inazuka, Tomomi Murao, Takashi Kurashige, Kazuya Kuraoka, Tetsuya Takahashi, Hirofumi Maruyama
Publikováno v:
Journal of Neuropathology and Experimental Neurology
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and antisignal recognition particle (SRP) antibodies are frequently associated with immune-mediated necrotizing myopathy (IMNM). However, the difference in clinical manifestations between a
Autor:
Kenichiro Ikeda, Masanobu Shigeta, Kenshiro Takemoto, Hiroyuki Kitano, Jun Teishima, Daiki Taniyama, Daiki Murata, Mayumi Kaneko, Kazuya Kuraoka, Keisuke Goto, Naohide Oue, Kazuhiro Sentani, Yohei Sekino, Shogo Inoue, Takashi Babasaki, Tetsutaro Hayashi, Kohei Kobatake, Koji Mita
Publikováno v:
Anticancer research. 41(10)
BACKGROUND/AIM Sunitinib continues to be administered as a first-line therapeutic agent in metastatic renal cell carcinoma (mRCC). This study examined the potential role of p53 in sunitinib resistance and as a predictive marker in mRCC. MATERIALS AND
Autor:
YOHEI SEKINO, KENSHIRO TAKEMOTO, DAIKI MURATA, TAKASHI BABASAKI, KOHEI KOBATAKE, HIROYUKI KITANO, KENICHIRO IKEDA, KEISUKE GOTO, SHOGO INOUE, TETSUTARO HAYASHI, DAIKI TANIYAMA, MASANOBU SHIGETA, KAZUYA KURAOKA, KOJI MITA, MAYUMI KANEKO, KAZUHIRO SENTANI, NAOHIDE OUE, JUN TEISHIMA
Publikováno v:
Anticancer research. 41(9)
Sunitinib continues to be administered as a first-line therapeutic agent in metastatic renal cell carcinoma (mRCC). This study examined the potential role of p53 in sunitinib resistance and as a predictive marker in mRCC.We analysed the effects of p5
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 61(3)
The multilocular thymic cyst (MTC) is a rare, acquired disease caused by inflammatory changes in the thymus, and is associated with autoimmune diseases. We report a case of MTC with thrombocytopaenia, which improved following surgical resection. A 45